Loss of the fructose transporter SLC2A5 inhibits cancer cell migration

Abstract excerpt

Metastasis is the primary cause of cancer patient death and the elevation of SLC2A5 gene expression is often observed in metastatic cancer cells. Here we evaluated the importance of SLC2A5 in cancer cell motility by silencing its gene. We discovered that CRISPR/Cas9-mediated inactivation of the SLC2A5 gene inhibited cancer cell proliferation and migration in vitro as well as metastases in vivo in several animal...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Diet, Metabolism, and Disease
• Share to Metabolism, Diabetes, and Cancer
• Share to Pancreatic function and diabetes